Dhampur Bio Organics Limited Earnings Summary — Q1 FY2027
Dhampur Bio Organics Reports Strong Q1 Recovery and Strategic Unit Sale
Quarterly Business Intelligence
AI Quarterly Scorecard™
Computed deterministically from the last 10 reported quarters.
Quarterly Business Momentum
- Revenue grew 16.0% sequentially in Q1 FY2027.
- Revenue of ₹533 Cr is 8.2% higher year-on-year.
- Revenue has compounded at 6.5% annualised over the last 10 quarters.
- Net profit of ₹37 Cr is 267.2% above the same quarter last year.
- Profit growth is outpacing revenue growth, pointing to positive operating leverage.
- Net profit has compounded at -5.4% annualised across the period.
- Operating margin stands at 1.7% in Q1 FY2027.
- Operating margin compressed by 9 bps year-on-year.
- Over the last two years operating margin has contracted by 537 bps.
- PBT margin is 6.0%.
- Expenses grew 8.3% against revenue growth of 8.2%.
- Operating profit of ₹9 Cr is 2.8% higher year-on-year.
- Operating leverage has been under pressure recently.
- 5 of the last 6 measured quarters delivered year-on-year revenue growth.
- Overall quarterly business momentum scores 50/100 (Moderate) on the latest 10 quarters.
- Business momentum remains positive heading into the next quarter.
Quarterly Financials
Last 10 Reported Quarters • All figures in ₹ Crore • Margins in %
| Metric | Trend | Latest Q1 FY2027 | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | Stable | 533 | 460 | 486 | 558 | 492 | 464 | 464 | 466 | 467 | 463 |
| Expenses | Improving | 524 | 380 | 444 | 566 | 484 | 369 | 448 | 476 | 434 | 382 |
| Operating Profit | Volatile | 9 | 80 | 43 | -8 | 9 | 96 | 16 | -10 | 33 | 81 |
| Operating Margin | Volatile | 1.7% | 17.4% | 8.8% | -1.4% | 1.8% | 20.6% | 3.4% | -2.1% | 7.0% | 17.5% |
| Other Income | Volatile | 52 | 15 | 9 | 13 | -6 | 1 | -1 | 1 | 1 | 5 |
| Interest | Improving | 16 | 14 | 11 | 14 | 19 | 20 | 10 | 16 | 21 | 18 |
| Depreciation | Stable | 13 | 13 | 15 | 15 | 12 | 16 | 15 | 11 | 12 | 14 |
| Profit Before Tax | Volatile | 32 | 69 | 26 | -23 | -29 | 61 | -10 | -35 | 1 | 54 |
| Tax | Volatile | -5 | 22 | 9 | -7 | -7 | 16 | -3 | -12 | 1 | 15 |
| Net Profit | Volatile | 37 | 46 | 17 | -16 | -22 | 45 | -7 | -23 | 0 | 39 |
| Net Margin | Volatile | 6.9% | 10.1% | 3.5% | -2.9% | -4.5% | 9.7% | -1.5% | -5.0% | 0.0% | 8.5% |
Key Takeaways
- Revenue increased by 8.33% YoY to ₹533 crore, reflecting steady operational growth in the sugar and bio-organics segments.
- Net Profit turned around significantly from a loss of ₹22 crore in the same quarter last year to a profit of ₹37 crore.
- Operating margins remain volatile at 1.69%, significantly down from the previous sequential quarter (Q4 FY26) despite the revenue growth.
- The Board approved the sale of the Meerganj sugar unit for a total consideration of ₹305 crore, resulting in a reported gain of ₹63.89 crore.
- Strategic shift evidenced by the recent 74% acquisition of DBION Private Limited to expand the company's bio-organic footprint.
- Strong balance sheet management shown by a reduced debt-to-equity profile compared to previous peak borrowing years.
Management Guidance
Management focused on asset optimization through the Meerganj unit sale to streamline operations and enhance liquidity for future growth in bio-organics.
Sentiment Shift
Improving
A return to profitability on a YoY basis and the significant cash infusion from the Meerganj sale strengthen the financial position.
Outlook
The outlook is bolstered by the divestment of non-core assets and the fresh capital which is expected to reduce interest burdens and fund high-growth bio-organic segments.
From the Annual Report (Key Quotes)
“Board approved Q1 FY27 results... Meerganj unit sold for ₹305 crore.”
“Sale of Meerganj unit resulted in a gain of ₹63.89 crore.”
“The company completed 74% acquisition of DBION Private Limited.”
Official Quarterly Documents
Ask AI about this quarter
This summary is AI-generated from Dhampur Bio Organics Limited's latest quarterly filing and earnings call. For informational purposes only — not investment advice.